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INTRODUCTION
• An overview of the problem
• Promoting wellbeing and resilience
• A solution to the problem - The BodyMind 
Approach
• Outcomes from the TBMA embedment project
• Patient, GP and commissioner comments
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WHAT ARE MEDICALLY UNEXPLAINED 
SYMPTOMS (MUS)?
• MUS -Previously known as psychosomatic 
conditions/MUPS
• Persistent, physical symptoms which do not appear to 
have an organic cause or respond to treatment
• Clinical & social predicament, includes broad spectrum 
of presentations, difficulty accounting for symptoms 
based on known pathology (Edwards et al 2010)
copyright, Professor Helen Payne, 
September 2014, EADMT conference
THE PROBLEM
• 8 common physical complaints account for 80 million physician 
visits annually in the USA (Lipsitt, 1996), yet an organic cause found 
for less than 25% of these symptoms (i.e. 75% MUS). 
• For 1,000 medical outpatients, 16% of symptoms had an organic 
cause, 10% presumed as causally related to psychological 
variables, leaving 3 out of 4 complaints unexplained medically 
(Kroenke & Mangelsdorf, 1989). (i.e. approx. 75% MUS)
• 191 new referrals to a general medical outpatient clinic, 52% of 
patients’ physical symptoms were medically unexplained (van 
Hermert, 1993). 
• “No serious medical cause" was the "diagnosis" in 25% - 50% of 
all primary care visits (Barsky & Borus, 1995).
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PERCENTAGE OF PATIENTS WITH  MUS
• Only 10% -15% of 14 common physical symptoms seen in primary care are 
found to be caused by an organic illness (i.e. 75% are MUS) (Morriss, 2007)
• Comprise 40% (in some over 50%) of medical outpatient appointments and 
5–10% of in-patient care, with limited evidence of benefit 
• 25-50% GP consultations with patients suffering MUS (Barsky; Borus, 1995)
• 10 of most common problems account for 40% of all visits, but GPs can 
identify a biological cause for the concern in only 26% (i.e. 14% of the 10 
most common symptoms MUS) (Nimnuan, 2001)
• Therefore we know MUS are very common, accounting for as many as 1 in 
5 new consultations in primary care (Bridges & Goldberg, 1985)
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CHARACTERISTICS OF PATIENTS WITH  MUS
• 70% suffer from depression (Malhi 2013) 
• Fewer years in formal education (Creed & Barsky 2004)
• Parental illness/neglect in childhood (for women) (Craig,
Cox, Klein 2002)
• Considerably worse quality of life compared with MES
• 50% more consultations; 50% more healthcare costs; 
33% more hospitalisations
• Generally high levels of health anxiety
• Uncertainty whether it is a physical problem or if 
symptoms are stress related 
• Unnecessary procedures/surgery- can create new health 
problems/increase anxiety
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CHARACTERISTICS OF PATIENTS WITH MUS 
• More sick leave & more likely to be unemployed 
• Comparable to MES in impairment of physical function 
(or greater)
• Poorer general health & worse mental health
• Poor affect regulation
• Needy of emotional support
• Past/current family dysfunction and/or a history of 
trauma, neglect or abuse 
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COST TO PATIENTS WITH MUS
Significant emotional costs,  for example :
1. Frustration & fear by the lack of a diagnosis 
2. Anxiety they have the big ‘C’ 
3. Assume only person for whom GP cannot find a 
diagnosis 
4. Isolation exacerbated
5. Variety of expensive, intrusive, sometimes painful 
tests/investigations/even unnecessary harmful, 
iterative surgery to no avail
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RESILIENCE IS THE ABILITY TO BOUCE BACK 
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PROMOTING RESILIENCE THROUGH 
THE BODYMIND APPROACH™
Resilience promotes the ability to recover by living well with 
symptoms, anxiety and/or depression. 
Resilience requires an adaption to adverse situations,  
cultivated in four areas :
• physical (working with the bodily symptoms)
• intellectual (psycho-education)
• emotional (more able to handle stress; wellbeing; 
acknowledging/processing feelings)
• relational (inter-subjectivity between each other and 
facilitator)
• spiritual (renewal as and when existential questions arise)
TBMA aims to incorporate all these aspects
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RESILIENCE
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THE RECOVERY MODEL
Used widely in the UK NHS mental health services 
and as applied to MUS it aims to:
• Cultivate a different perception of symptoms 
and valuing of the body
• Reflect a relatively positive adaptation despite 
significant symptom phenomena as stressors
• Foster protective factors which buffer the 
negative effects of stress and bodily symptoms
copyright, Professor Helen Payne, 
September 2014, EADMT conference
copyright, Professor Helen Payne, 
September 2014, EADMT conference
A SOLUTION TO THE PROBLEM - THE 
BODYMIND APPROACH (TBMA)™
• Derived from an integration of DMP i.e. 
authentic movement/body awareness, with 
mindfulness;  group work; integrative 
psychotherapy
• Physical symptom acts as gateway to the mind
• ‘Playing with the symptom so it does not play 
on you’
• Promotes resilience leading towards Recovery 
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THE  MUS CLINIC
• New, effective treatment for patients with broad 
range of chronic, persistent symptoms
• Complimentary to CBT/Psychotherapy
• Offers a ‘both’ - ‘and’ not an ‘either’/ ‘or’ for referral 
to secondary care  
• Group format 
• A bio-psychosocial approach 
• Informed by Neuroscience  research (Cozolino, 2002) 
• The clinical programme lasts 12 months, two phases
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THE TBMA EMBEDMENT PROJECT
• Based on pilot (Payne & Stott 2010) 
• Taking account of conversion and dissociation 
present in MUS (Lin & Payne 2014)
• Practice-based research
• NHS changes from April 2013 included: 
Clinical Commissioning Groups replaced Primary 
Care Trusts; GPs accountable for contracting, 
budget spend, patient safety; H&WB boards; GP 
recruitment; Care Quality Commission; Health & 
Social Care integration (plus Education for children)
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GENERAL WELLBEING
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Pie Chart 1: Percentage of patients reporting increased general wellbeing  
62.5% of patients report improvement in their feeling of general wellbeing 
Pie Chart 1: Key: blue=62.5%; green 25%; red 12.5% 
 
 
 
general wellbeing
increased wellbeing
decreased wellbeing
no change
ACTIVITY LEVELS
Pie Chart 2: Percentage of patients reporting improved activity 
56.25% of patients report improved activity
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improved activity
56.25% improved activity
0% decreased activity 0%
43.75%no change
MYMOP OVERALL
Pie Chart 3: Percentage of patients reporting increased overall 
score for MYMOP including activity, symptom severity and 
wellbeing
81.25% of patients report improvement in overall scores
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mymop overall
81.25% increased
6.25% decreased
12.5% no change
SYMPTOM SEVERITY 
Pie Chart 4: Percentage of patients reporting Symptom Severity 
65.3% of patients reported an improvement in symptoms
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symptom severity
65.3%decrease 7.6%increase
26.9%no change
DEPRESSION
Pie Chart 5: Patients reporting reduced feelings of depression 
81.25% of patients reported a reduction in depression
copyright, Professor Helen Payne, 
September 2014, EADMT conference
depression
81.25% reduced
6.25% increased
12.5% no change
ANXIETY
Pie Chart 6: percentage of patients reporting reduced anxiety 
levels 
68.75% of patients reported a reduction in anxiety
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anxiety
68.75% reduced
12.5% increased
18.75% no change
GLOBAL FUNCTIONING
Pie Chart 7: Percentage of patients reporting improved Global 
Functioning 
81.25% of patients report and improvement in global functioning
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global functioning
81.25% improved
6.25% reduced
12.5% no change
Example of percentage improvement in social 
support, medication, GP & hospital visits
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Improvement in function pre to post-group shown as patient 
numbers & percentages MYMOP2; PHQ9; GAD7; GAF
Test Improved Worsened No Change
Depression
PHQ9
13/16 (81.25%) 1/16 (6.25%) 2/16 (12.5%)
Global Functioning
GAF
13/16 (81.25%) 1/16 (6.25%) 2/16 (12.5%)
Overall
MYMOP2
13/16 (81.25%) 1/16 (6.25%) 2/16 (12.5%)
Anxiety
GAD7
11/16 (68.75%) 2/16 (12.5%) 3/16 (18.75%)
Symptoms
MYMOP2
17/26 (65.3%) 2/26 (7.6%) 7/26 (26.9%)
General Wellbeing
MYMOP2
10/16 (62.5%) 12/16 (12.5%) 4/16 (25%)
Activity
MYMOP2
9/16 (56.25%) 0 7/16 (43.75%)
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FOLLOW UP OUTCOMES
The six month post group follow up analysis compared to post group: 
• Improvements not only sustained at 3 months post group (pilot) re 
but continued to maintain/improve further at the 6 month stage in:
functioning 
wellbeing
anxiety 
depression 
symptom distress
The six month post group compared to pre-group analysis showed:
• Improvement or maintenance of activity levels (50% of people becoming more 
active /50% remaining the same when compared to pre-group)
• Improved well-being was maintained in 50% of people at post-group when 
compared to pre group
• Improvement in social, occupational and overall functioning in 75% of 
people when compared to pre group)
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SELF MANAGED CARE
• Patients have demonstrated their capacity for 
resilience post TBMA group intervention
• Patient management of their symptoms became 
habitual over time
• Patients sustained feelings of wellbeing giving 
them greater inner resources to cope when 
symptoms were experienced
• Feelings of empowerment was cultivated to 
control their symptoms over time leading to self 
managed care reducing dependence on the NHS, 
thus saving resources and increasing GP capacity
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PATIENT EVALUATION 
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“It was helpful to be in a 
group of people sharing 
similar problems” 
“I wish it had been available 5 years ago 
when the symptoms started”
“The group was 
good in that we 
spoke and 
listened to each 
other “
“The focus was on the 
MUS issues”
“There was a 
freedom of 
expression and 
an alternative 
way to consider 
coping with my 
problems”
“Achieved a return to 
work and overcoming 
of fibromyalgia” 
QUOTATIONS FROM COMMISSIONERS
• ‘We are very impressed with not only the quality of the 
service being delivered but also the thoroughness and 
professionalism of the organisation behind delivering this 
service’
• ‘I can unreservedly endorse and recommend them as an 
organisation which will deliver their services to the highest 
professional and ethical standards’ 
• ‘They have the benefit of having national leading expertise in 
the treatment of MUS and have proven themselves as 
extremely capable of running learning/treatment groups for 
patients and training staff’
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COMMENTS FROM GPs
“What an excellent 
service, my patient 
has never returned 
and he was coming 
every week and 
writing long letters 
to  me”
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THANK YOU FOR YOUR TIME 
ANY COMMENTS/QUESTIONS ?
Professor Helen Payne
H.L.Payne@herts.ac.uk
www.pathways2wellbeing.com
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